London Health Science Center

London, Ontario N6C 5A5

0 studies enrolling now · 10 studies all time

What they study most

Chronic Kidney Disease, Critical Illness, Deep Venous Thrombosis, Gastrointestinal Disease, Inflammatory Bowel Disease, Infrarenal Abdominal Aortic Aneurysm, Liver Fibrosis Due to NASH, Lymphoma, Non-Hodgkin's, Osteoarthritis, Ovarian Neoplasms, Parkinson's Disease, Primary Sclerosing Cholangitis (PSC)

Studies at this site

• A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease — Completed
• Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) — Completed
• A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2) — Completed
• Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) — Stopped early
• The Vascutek AnacondaTM Stent Graft System Phase II IDE Study — Completed
• R3® Acetabular System in Patients With Degenerative Hip Disease — Completed
• A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma — Completed
• Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer — Stopped early
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) — Completed
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis — Completed